Valiant Laboratories Limited (NSE:VALIANTLAB)
54.95
-0.82 (-1.47%)
Mar 10, 2026, 10:40 AM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 3.03 billion as of March 9, 2026. Its market cap has decreased by -29.75% in one year.
Market Cap
3.03B
Enterprise Value
2.94B
Revenue
2.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
54.95
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 3.03B, a decrease of -59.05%. That is a compound annual growth rate of -30.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.90B | -23.76% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bafna Pharmaceuticals | 2.65B |
| Nectar Lifesciences | 2.27B |
| Brooks Laboratories | 1.80B |
| Alpa Laboratories | 1.34B |
| Sigachi Industries | 7.31B |
| Par Drugs and Chemicals | 1.13B |
| Vaishali Pharma | 879.31M |
| Beta Drugs | 11.08B |